Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Neuprex receives orphan drug designation for treatment of severe meningococcal disease

June 29, 1998

Interference with production of virulence factors as novel antibacterial strategy

June 26, 1998

FDA approves first new drug for tuberculosis in 25 years

June 26, 1998

Another market introduction for cidofovir

June 25, 1998

Nabi licenses technology for development of antiviral drug

June 24, 1998

Substituted carbapenems for Gram-positive infections designed at Merck & Co.

June 24, 1998

Abbott patents improved ketolide antibacterial agents

June 24, 1998

Nyotran compared to free nystatin and amphotericin B formulations in vitro

June 23, 1998

FDA approves biotech product for RSV disease in children

June 22, 1998

New macrolide antibiotic derivatives from Pfizer

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...